Rifampin phosphotransferase is an unusual antibiotic resistance kinase
Peter J. Stogios,
Georgina Cox,
Peter Spanogiannopoulos,
Monica C. Pillon,
Nicholas Waglechner,
Tatiana Skarina,
Kalinka Koteva,
Alba Guarné,
Alexei Savchenko () and
Gerard D. Wright ()
Additional contact information
Peter J. Stogios: University of Toronto
Georgina Cox: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Peter Spanogiannopoulos: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Monica C. Pillon: McMaster University
Nicholas Waglechner: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Tatiana Skarina: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Kalinka Koteva: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Alba Guarné: McMaster University
Alexei Savchenko: University of Toronto
Gerard D. Wright: M.G. DeGroote Institute for Infectious Disease Research, McMaster University
Nature Communications, 2016, vol. 7, issue 1, 1-12
Abstract:
Abstract Rifampin (RIF) phosphotransferase (RPH) confers antibiotic resistance by conversion of RIF and ATP, to inactive phospho-RIF, AMP and Pi. Here we present the crystal structure of RPH from Listeria monocytogenes (RPH-Lm), which reveals that the enzyme is comprised of three domains: two substrate-binding domains (ATP-grasp and RIF-binding domains); and a smaller phosphate-carrying His swivel domain. Using solution small-angle X-ray scattering and mutagenesis, we reveal a mechanism where the swivel domain transits between the spatially distinct substrate-binding sites during catalysis. RPHs are previously uncharacterized dikinases that are widespread in environmental and pathogenic bacteria. These enzymes are members of a large unexplored group of bacterial enzymes with substrate affinities that have yet to be fully explored. Such an enzymatically complex mechanism of antibiotic resistance augments the spectrum of strategies used by bacteria to evade antimicrobial compounds.
Date: 2016
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/ncomms11343 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11343
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/ncomms11343
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().